National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 2) (PB 20 of 2018) (Cth)

Case

PB 20 of 2018

National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 2)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated   26th March 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

  1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 2).

(2)This Instrument may also be cited as PB 20 of 2018.

  1. Commencement

This Instrument commences on 1 April 2018.

  1. Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1]Schedule 1, entry for Amoxycillin in the form Capsule 250 mg (as trihydrate)

a)omit from the column headed “Determined Price”:           1.30        substitute:             1.37

b)omit from the column headed “Claimed Price”:                 4.55        substitute:             4.61

[2]Schedule 1, entry for Amoxycillin in the form Capsule 500 mg (as trihydrate)

a)     omit from the column headed “Determined Price”:                                1.60        substitute:             1.63

b)    omit from the column headed “Claimed Price”:   5.10        substitute:             5.12

[3]Schedule 1, entry for Amoxycillin in the form Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL

a)     omit from the column headed “Determined Price”:                                3.42        substitute:             5.88

b)    omit from the column headed “Claimed Price”:   3.92        substitute:             6.37

[4]Schedule 1, entry for Atenolol

omit from the column headed “Claimed Price”:   3.33        substitute:             7.33

[5]Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg

omit from the column headed “Claimed Price”:   4.15        substitute:             6.65

[6]Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg

omit from the column headed “Claimed Price”:   5.01        substitute:             7.52

[7]Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg

omit from the column headed “Claimed Price”:   7.56        substitute:             10.06

[8]Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg

omit from the column headed “Claimed Price”:   10.81     substitute:             13.62

[9]Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg

omit from the column headed “Claimed Price”:   7.84        substitute:             10.34

  1. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg

omit from the column headed “Claimed Price”:   13.42     substitute:             15.40

  1. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

omit from the column headed “Claimed Price”:   12.80     substitute:             15.76

  1. Schedule 1, entry for Doxepin in the form Capsule 10 mg (as hydrochloride)

a)     omit from the column headed “Determined Price”:                                2.69        substitute:             3.49

b)    omit from the column headed “Claimed Price”:   9.20        substitute:             10.00

  1. Schedule 1, entry for Doxepin in the form Capsule 25 mg (as hydrochloride)

a)     omit from the column headed “Determined Price”:                                2.79        substitute:             4.52

b)    omit from the column headed “Claimed Price”:   9.30        substitute:             11.03

  1. Schedule 1, after entry for Methyldopa

insert:

Methylphenidate Tablet containing methylphenidate hydrochloride 10 mg Oral Ritalin 10 100 8.50 10.00
  1. Schedule 1, entry for Omeprazole

omit from the column headed “Claimed Price”:   6.97        substitute:             10.97

  1. Schedule 1, after entry for Propranolol in the form Tablet containing propranolol hydrochloride 40 mg

insert:

Quetiapine Tablet (modified release) 50 mg (as fumarate) Oral Seroquel XR 60 10.86 15.66
Tablet (modified release) 150 mg (as fumarate) Oral Seroquel XR 60 15.36 25.36
Tablet (modified release) 200 mg (as fumarate) Oral Seroquel XR 60 31.60 33.60
Tablet (modified release) 300 mg (as fumarate) Oral Seroquel XR 60 40.59 42.59
Tablet (modified release) 400 mg (as fumarate) Oral Seroquel XR 60 55.33 57.33
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0